Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release

Newsdesk: